1 suspended, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Suspended 1, Withdrawn 1 |
| Phase 2 | 1 | Suspended 1 |
Follow Exsar Corporation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease Ambroxol - Type I Gaucher Disease | Phase 1 / Phase 2 | Suspended | Exsar Corporation | 20 | 2012-12-01 | 2013-02-15 |
| A Phase I Study of Pyrimethamine in Patients With GM2 Gangliosidosis Pyrimethamine - G(M2) Ganglioside, Tay-Sachs Disease Ganglioside | Phase 1 | Withdrawn | Exsar Corporation | 2008-05-01 | 2013-02-25 |
Gangliosidoses, GM2 (1) · Gaucher Disease (1) · Sandhoff Disease (1) · Tay-Sachs Disease (1)
Ambroxol (1) · Pyrimethamine (1)
United States (2) · Canada (1)
Bijan Almassian, Ph.D. (1) · Robert Johnston (1)